StockNews.com Downgrades Electromed (NYSE:ELMD) to Buy

Electromed (NYSE:ELMD) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Thursday.

Electromed Stock Down 4.3 %

Shares of NYSE ELMD opened at $29.77 on Thursday. Electromed has a 52-week low of $9.90 and a 52-week high of $31.88. The stock has a market capitalization of $251.85 million, a price-to-earnings ratio of 41.35 and a beta of 0.29. The stock’s fifty day simple moving average is $28.56 and its 200 day simple moving average is $21.47.

Electromed (NYSE:ELMD) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.13. The company had revenue of $14.67 million during the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Insider Buying and Selling at Electromed

In other Electromed news, Director Andrew Summers sold 17,463 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $30.09, for a total value of $525,461.67. Following the transaction, the director now owns 189,838 shares in the company, valued at approximately $5,712,225.42. This represents a 8.42 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 14.00% of the company’s stock.

Hedge Funds Weigh In On Electromed

Several institutional investors and hedge funds have recently modified their holdings of ELMD. Renaissance Technologies LLC raised its holdings in shares of Electromed by 4.8% during the second quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock worth $1,548,000 after acquiring an additional 4,736 shares in the last quarter. Pekin Hardy Strauss Inc. purchased a new stake in shares of Electromed during the 2nd quarter worth about $522,000. Gabelli Funds LLC lifted its holdings in shares of Electromed by 7.8% during the 2nd quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock valued at $581,000 after buying an additional 2,808 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of Electromed in the 2nd quarter valued at approximately $256,000. Finally, Hunter Associates Investment Management LLC increased its holdings in Electromed by 12.3% in the third quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock worth $2,199,000 after buying an additional 11,250 shares during the last quarter. 40.82% of the stock is currently owned by hedge funds and other institutional investors.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.